Pfizer Expands Free AIDS Drug Program

Pfizer Inc. will expand its free distribution of a drug for AIDS patients in 50 of the world’s least developed countries. The drug, Diflucan, is already being distributed free in South Africa as a treatment for cryptococcal meningitis, an infection of the brain that occurs in 10% of AIDS patients. It also treats esophageal candidiasis, a fungal infection of the esophagus reported in 20% to 40% of the patients.

The drug is currently being shipped to South Africa and distributed in 185 clinics there. In the United States, the drug costs $10 per dose and those suffering from cryptococcal meningitis may need a lifelong daily regimen. AIDS patients with this form of meningitis are usually believed to have a few years to live.

The Pfizer announcement comes just weeks before the U.N. General Assembly’s special session on HIV/AIDS that is expected to adopt a global action plan to combat the epidemic.

The New York-based company says the program in South Africa will cost it about $50 million over the next two years.